12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gattex regulatory update

NPS said FDA extended the PDUFA date by 3 months for an NDA for Gattex teduglutide to treat short bowel syndrome (SBS). The new date is Dec. 30; it was Sept. 30....

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >